11/13/2025
Unfortunately , RSV season has started.
We do however offer the Beyfortus Immunization to help protect your baby!!
What is Beyfortus❓
Beyfortus is not a vaccine or maternal immunization. Beyfortus is an RSV F protein-directed fusion inhibitor monoclonal antibody indicated for the prevention of RSV lower respiratory tract disease—directly administered to the infant as well as eligible children via IM injection. This does not require an immune response from the infant.¹ This immunization may not prevent the child from getting RSV but it can prevent the child from developing a severe case of RSV.
Beyfortus was approved by the FDA July 2023.
❓Who is eligible?
Neonates and infants born during or entering their first RSV season. Usually, these patients are 8 mo or younger.
👼Children up to 24 months of age who remain vulnerable to severe RSV disease through their second season. Such as patients with chronic lung or heart disease.
If you have any questions or would like to schedule an appt, please call 270-789-1112 ASAP.
